RecruitingNot ApplicableNCT05541887

Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health

Acute and Chronic Impacts of Muscadine Wine Polyphenols on Cognition, Memory, Mood, and Anxiety in Adults Over 50 Years of Age


Sponsor

University of Florida

Enrollment

25 participants

Start Date

Aug 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating inflammation and oxidative stress, and/or inhibiting monoamine oxidase activities


Eligibility

Min Age: 50 YearsMax Age: 65 Years

Inclusion Criteria3

  • Healthy
  • BMI (18.5-29.9)
  • Body weight ≥110 pounds

Exclusion Criteria12

  • Pregnancy
  • Breast-feeding
  • Smokers
  • Diabetic
  • Heavy drinkers
  • Subjective but not clinically diagnosed cognitive impairment (Montreal cognitive assessment score \<26),
  • Inability to understand the cognitive function tasks
  • Intake of medication that might influence the outcome of the study (e.g. psychostimulant)
  • cannabis product user
  • Clinically diagnosed mental illnesses
  • Cardiovascular and neurological disorders
  • Uncontrolled hypertension

Interventions

OTHERMuscadine Wine Polyphenol

dealcoholized muscadine wine with alcohol content \<0.5% with addition of 50ppm of sodium metabisulfite for preservation

OTHERPlacebo

this placebo beverage is formulated with matching sugar and organic acid content to the muscadine wine polyphenol. Food coloring is added to match the color of the intervention. 50ppm of sodium metabisulfite for preservation


Locations(1)

Food Science and human nutrition department at University of Florida

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05541887


Related Trials